ASPREE trial shows aspirin does not prevent cognitive decline in healthy elderly
Landmark trial shows aspirin does not prevent cognitive decline in healthy elderly PRESS RELEASE: 1st April 2020 – Melbourne Researchers at Monash University and the Berman Center for Outcomes and Clinical Research in the US, have found that daily aspirin does not reduce the risk of Alzheimer’s disease, mild cognitive impairment, or cognitive decline…
Details